<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">WJA</journal-id><journal-title-group><journal-title>World Journal of AIDS</journal-title></journal-title-group><issn pub-type="epub">2160-8814</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/wja.2022.122005</article-id><article-id pub-id-type="publisher-id">WJA-117362</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Rating of CCR5-Delta 32 Homozygous Mutation in Sudanese HIV Patients and Sex Workers
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mawaib</surname><given-names>Hassan Fath-Elrahman</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mubarak</surname><given-names>Alkarsany</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bakri</surname><given-names>Yousif Mohammed Nour</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Adam</surname><given-names>Dawoud Abakar</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Abdelrahman</surname><given-names>Eldaw Mhammed</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Salaheldein</surname><given-names>Gumma Elzaki</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Eman</surname><given-names>Osman</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mubarak</surname><given-names>Elshafia</given-names></name><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Elhadi</surname><given-names>Abdalla Ahmed</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib></contrib-group><aff id="aff5"><addr-line>Molecular Biology Laboratory, Department of Epidemiology, Tropical Medicine Research Institute, Khartoum, Sudan</addr-line></aff><aff id="aff6"><addr-line>National Tuberculosis Reference Laboratory, National Public Health Laboratory, Khartoum, Sudan</addr-line></aff><aff id="aff3"><addr-line>Department of Medical Parasitology, Faculty of Medical Laboratory Sciences, University of Gezira, Wad Medani, Sudan</addr-line></aff><aff id="aff4"><addr-line>Department of Medical Microbiology, Faculty of Medical Laboratory Sciences, University of Gezira, Wad Medani, Sudan</addr-line></aff><aff id="aff1"><addr-line>Department of Virology, National Public Health Laboratory, Khartoum, Sudan</addr-line></aff><aff id="aff2"><addr-line>Department of Medical Laboratory Sciences, Karary University, Khartoum, Sudan</addr-line></aff><aff id="aff7"><addr-line>Department of Haematology and Immunohaematology, Faculty of Medical Laboratory Sciences, University of Gezira, 
Wad Medani, Sudan</addr-line></aff><pub-date pub-type="epub"><day>11</day><month>04</month><year>2022</year></pub-date><volume>12</volume><issue>02</issue><fpage>55</fpage><lpage>64</lpage><history><date date-type="received"><day>28,</day>	<month>March</month>	<year>2022</year></date><date date-type="rev-recd"><day>23,</day>	<month>May</month>	<year>2022</year>	</date><date date-type="accepted"><day>26,</day>	<month>May</month>	<year>2022</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background: Prevention against human immunodeficiency virus (HIV) includes natural resistance in the population; mainly frequency of cysteine-cysteine chemokine receptor type-5 (CCR5-delta 32 mutation). By knowing the frequency of this resistance in the community, the proportion of the population susceptible to infection can be determined. This study aimed to detect for the first time the rate of CCR5-delta 32 mutation in Sudanese individuals with HIV and sex workers. 
  Methods: Cross-sectional study was followed in the parade from 2019 through 2021, study groups were Sudanese with HIV and sex workers. Sero-negativity of sex workers was confirmed by a rapid immunochromatography test (ICT). A blood sample was targeted for DNA isolation. PCR amplification was accomplished for CCR5 wild type and CCR5-delta 32 mutation genes using specific primers.
   Result: Among HIV patients, males, basic education level and ages below 60 years were commonly recorded while ages below 40 years, secondary education level and single marital status were predominated in sex workers. All HIV patients were positive for CCR5 wild type and negative for CCR5-delta 32 genotype. The sex workers group showed a frequency of 3.5% (97/200) for homozygous CCR5-delta 32 mutation. 
  Conclusion: The rating of homozygous CCR5-delta 32 genotype in studied Sudanese sex workers was relatively more than other results obtained from African countries, and the mutation was significantly detected among sex workers group (P value = 0.008) when compared to the studied HIV group.
 
</p></abstract><kwd-group><kwd>CCR5-Delta 32</kwd><kwd> HIV</kwd><kwd> Sex Workers</kwd><kwd> Rating</kwd><kwd> Sudan</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>According to the facts of the World Health Organization (WHO), human immunodeficiency virus (HIV) and AIDS is the most important threat to global health [<xref ref-type="bibr" rid="scirp.117362-ref1">1</xref>], despite this fact, the number of people living with HIV (PLHIV) is increasing rapidly [<xref ref-type="bibr" rid="scirp.117362-ref2">2</xref>]. The prevalence of HIV in Sudan increased in 1998 to reach 2% and remained at this level until 2020, as documented by the World Bank [<xref ref-type="bibr" rid="scirp.117362-ref3">3</xref>], this level keeps Sudan in the ranks of countries with a low prevalence rate, although its geographical surroundings with several highly affected countries. In 2016 estimated and reported number of PLHIV in Sudan was 56,000 and 21,471 respectively, while prevalence among sex workers increases to 1.3% [<xref ref-type="bibr" rid="scirp.117362-ref3">3</xref>].</p><p>One of the major co-receptor of HIV-1 and HIV-2 for entry into the human macrophages during initial infection is the cysteine-cysteine chemokine receptor type 5 (CCR5) [<xref ref-type="bibr" rid="scirp.117362-ref4">4</xref>]. Another important receptor necessary for HIV entrance is known as CXC chemokine receptor type 4 (CXCR4) [<xref ref-type="bibr" rid="scirp.117362-ref5">5</xref>]. Depending on the use of receptors CCR5 and CXCR4, the virus strain that uses receptors 5 is called R5-tropic, and studies indicated the predominance of this strain in the process of HIV transmission through sexual contact [<xref ref-type="bibr" rid="scirp.117362-ref6">6</xref>].</p><p>The most documented mutation of the CCR5 gene that affects HIV infection is known as the CCR5-delta 32 mutation; which could be existent as homozygous or heterozygous. In fact, people who are naturally protected against HIV carry homozygous type, while those who carry heterozygous have a late onset of AIDS symptoms [<xref ref-type="bibr" rid="scirp.117362-ref7">7</xref>]. Further to that, a study documented that individuals carrying homozygous type of CCR5-delta 32 gene remained uninfected with HIV-1 even with multiple exposures to the virus [<xref ref-type="bibr" rid="scirp.117362-ref8">8</xref>]. But in contrast, other findings concluded that protection against infection is related to both types of CCR5-delta 32 genotypes [<xref ref-type="bibr" rid="scirp.117362-ref9">9</xref>].</p><p>International surveillance of CCR5-delta 32 occurrence showed the highest frequency in North European countries, while the lowest rating was found in sub-Saharan countries [<xref ref-type="bibr" rid="scirp.117362-ref10">10</xref>]. Information regarding the existence and role of CCR5-delta 32 mutations in Sudan and most African countries is insufficient for a better understanding of the HIV transmission patterns [<xref ref-type="bibr" rid="scirp.117362-ref11">11</xref>]. On the other hand, the existence of the CCR5-delta 32 genetic mutations has negative effects that have been identified, represented in responses to chronic liver disease and antiviral drugs [<xref ref-type="bibr" rid="scirp.117362-ref12">12</xref>].</p><p>We observed only one published study in the Sudanese population done to identify the CCR5-delta 32 allele in patients with sickle cell anemia, in which the obtained result was none [<xref ref-type="bibr" rid="scirp.117362-ref12">12</xref>], thus the present study conducted to rate for the first time the frequency of CCR5-delta 32 mutations in Sudanese HIV patients and sex workers.</p></sec><sec id="s2"><title>2. Methods</title><p>Study Design and Setting</p><p>This cross-sectional laboratory based study was conducted at Wad Madani and Khartoum Antiretroviral Treatment Centers in 2019 and 2021. Wad Madani center is located in central Sudan in Gezira State which is a well populated area.</p><p>Selecting Participants and Variables</p><p>Participants of the study were adult volunteers randomly selected, and categorized into two groups; known patients with sero-positivity to HIV and healthy sex workers as a risk group. HIV patients were from Khartoum whereas sex workers were recruited from Wad Madani city in Gezira State. The HIV serological status of the sex workers group was negative. HIV patients participated before antiretroviral treatment (ART) administration. Variables of HIV patients and sex workers groups assessed in this study included socio-clinical and risk perception data.</p><p>Sampling</p><p>A total of 400 individuals were included; 200 from each group. Venous blood samples were obtained in EDTA anticoagulant. The formula of sample size is as the following:</p><p>The study sample size was 400 subjects which were determined according to the following formula:</p><p>n = z 2 p q d 2</p><p>n: sample size, z: confidence level at 95% = 1.96, p: proportion in the target population to have a particular disease = 0.5, q: 1 − p and d: degree of accuracy desired = 0.05.</p><p>384 = 1.96 2 ∗ 0.5 ∗ 0.5 0.05 2</p><p>DNA Extraction</p><p>The DNA was extracted using G-DEX IIb Genomic DNA Extraction kits; 300 &#181;l of whole blood was added into 1.5 ml eppendorf tubes containing 900 &#181;l RBC lysis solutions. Tubes were mixed thoroughly by vortexing and incubated for 5 minutes at room temperature and inverted again during the incubation. Centrifugation was done at 10.000 rpm for 1 minute. The supernatant was removed except for the white cell pellet and remained about 50 - 100 &#181;l. The tube was vortexed vigorously and cells were resuspended. Then 300 &#181;l cell lysis solution was added to the cells and shacked up and down to lyses the cells. A 1.5 &#181;l RNase was added to the solution and incubated at 37˚C for 15 minutes. The sample was chilled at room temperature, and 100 &#181;l of protein precipitation buffer was added to the cell lysate and vortexed vigorously at high speed for 20 seconds. Then a centrifugation at 13.000 rpm for 5 minutes was performed. The precipitated proteins formed a tight white pellet. A 300 &#181;l of supernatant containing the DNA was transferred into a 1.5 ml eppendorf tube. A 300 &#181;l of 100% isopropanol was added and mixed by inverting gently for several times. The mixtures were centrifuged at 13.000 for 1 minute, the DNA was visible as a small white pellet. The supernatant was poured off and the tube drained briefly on clean absorbent paper. 1ml of 70% ethanol was added and the tube was inverted several times to wash the DNA pellet, and centrifuged at 13.000 rpm for 1 minute, then the ethanol was carefully poured off. Tubes were inverted and drained on the clean absorbent paper and allowed to air dry for 10 - 15 minutes. Finally, 150 &#181;l of rehydration buffer was added and then rehydrate the DNA by incubating at 65˚C for 30 min. DNA was stored at −20˚C.</p><p>DNA purity was measured using a spectrophotometer at 260 nm wavelength and optical density ratio at the wavelength of 260/280 respectively.</p><p>Amplification of CCR5 Gene</p><p>PCR was done to amplify CCR5 wild type and CCR5-delta 32DNA using primer pairs (Macrogen, Europe, and Genomics). Primers were prepared as instructed by manufactures. 13 &#181;l of nuclease free water and 1&#181;l from each forward (5'CTGTGTTTGCGTCTCTCCCA’3) and revered primer (3’CCTCTTCTTCTCATTTCGACA’5) was added into PreMix tube Maxime and 5 &#181;l from DNA to a final volume of 20 &#181;l. Then the reaction was performed using a Bio-Rad thermocycler (USA), the program initiated with a first denaturation step at 94˚C for 5 min; followed by 30 cycles at 94˚C for 1 min, 65˚C for 1 min, 72˚C for 2 min, and a final extension at 72˚C for 5min and 4˚C hold temperature. Amplicon was resolved and screened using 1.5% agarose dissolved in 1XTBE (10.8 gm, Tris, 5.5 gm boric acid and 4 ml 0.5 M EDTA in a final volume of 1000 ml), and the mixture was boiled in a microwave. After cooling 5 μl of ethidium bromide (20 mg/ml) were added, mixed well and poured into a casting tray, and left to solidify at room temperature.</p><p>Data Analysis</p><p>The qualitative results of the study were analyzed descriptively for frequency determination. Chi-Square was calculated for association detection and the values less than 0.05 were considered significant. The Statistical Package for the Social Sciences (SPSS version 20) used analysis.</p><p>Ethical Approval</p><p>Ethical approval was obtained from the Gezira State Ministry of Health, Sudan and the Faculty of Medical Laboratory Sciences, University of Gezira, Sudan.</p></sec><sec id="s3"><title>3. Results</title><p>For HIV participants, males accounted for 71% (142/200), the age group of 60 years and above were the less frequent at 5.5% (11/200) and basic education level was recorded at 88% (177/200). No co-morbidity or HIV treatments were documented (<xref ref-type="table" rid="table1">Table 1</xref>). In contrast, sex worker group involved participants in the secondary education level with percentage of 100% (200/200) and female rating reaching 54% (107/200) (<xref ref-type="table" rid="table2">Table 2</xref>). Yielded quality of extracted DNA of HIV</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Distribution of socio-demographic characters of Sudanese HIV participants. No 200</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"  ></th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >%</th></tr></thead><tr><td align="center" valign="middle"  rowspan="2"  >Gender</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >142</td><td align="center" valign="middle" >71</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >58</td><td align="center" valign="middle" >29</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Age/year</td><td align="center" valign="middle" >Less than 40</td><td align="center" valign="middle" >97</td><td align="center" valign="middle" >48.5</td></tr><tr><td align="center" valign="middle" >40 to 60</td><td align="center" valign="middle" >92</td><td align="center" valign="middle" >46</td></tr><tr><td align="center" valign="middle" >More than 60</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >5.5</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Residence</td><td align="center" valign="middle" >Khartoum</td><td align="center" valign="middle" >190</td><td align="center" valign="middle" >95</td></tr><tr><td align="center" valign="middle" >Other</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >5</td></tr><tr><td align="center" valign="middle"  rowspan="7"  >Occupation</td><td align="center" valign="middle" >Students</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >9</td></tr><tr><td align="center" valign="middle" >Houswifes</td><td align="center" valign="middle" >35</td><td align="center" valign="middle" >17.5</td></tr><tr><td align="center" valign="middle" >Drivers</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >5.5</td></tr><tr><td align="center" valign="middle" >Workors</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >2.5</td></tr><tr><td align="center" valign="middle" >Emoplyees</td><td align="center" valign="middle" >74</td><td align="center" valign="middle" >37</td></tr><tr><td align="center" valign="middle" >Soliders</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >Non-empolyee</td><td align="center" valign="middle" >55</td><td align="center" valign="middle" >27.5</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Educational level</td><td align="center" valign="middle" >University</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >8</td></tr><tr><td align="center" valign="middle" >Secondary</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >3.5</td></tr><tr><td align="center" valign="middle" >Basic</td><td align="center" valign="middle" >177</td><td align="center" valign="middle" >88.5</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Marital status</td><td align="center" valign="middle" >Married</td><td align="center" valign="middle" >94</td><td align="center" valign="middle" >47</td></tr><tr><td align="center" valign="middle" >Single</td><td align="center" valign="middle" >105</td><td align="center" valign="middle" >52.5</td></tr><tr><td align="center" valign="middle" >widowed</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.5</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Co-morbidity</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >200</td><td align="center" valign="middle" >100</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >HIV treatment</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >200</td><td align="center" valign="middle" >100</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >HIV duration/year</td><td align="center" valign="middle" >Less than 14</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >More than 14</td><td align="center" valign="middle" >200</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Demographics and risk factors observed among Sudanese sex worker participants. No 200</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"  ></th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >%</th></tr></thead><tr><td align="center" valign="middle"  rowspan="2"  >Gender</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >94</td><td align="center" valign="middle" >47</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >107</td><td align="center" valign="middle" >54</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Age/year</td><td align="center" valign="middle" >Less than 40</td><td align="center" valign="middle" >121</td><td align="center" valign="middle" >60.5</td></tr><tr><td align="center" valign="middle" >40 to 60</td><td align="center" valign="middle" >79</td><td align="center" valign="middle" >39.5</td></tr><tr><td align="center" valign="middle" >More than 60</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Residence</td><td align="center" valign="middle" >Gezira State</td><td align="center" valign="middle" >200</td><td align="center" valign="middle" >100</td></tr><tr><td align="center" valign="middle" >Other</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Educational level</td><td align="center" valign="middle" >University</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Secondary</td><td align="center" valign="middle" >200</td><td align="center" valign="middle" >100</td></tr><tr><td align="center" valign="middle" >Basic</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Marital status</td><td align="center" valign="middle" >Married</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >9</td></tr><tr><td align="center" valign="middle" >Single</td><td align="center" valign="middle" >182</td><td align="center" valign="middle" >91</td></tr><tr><td align="center" valign="middle" >widowed</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >HIV</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >200</td><td align="center" valign="middle" >100</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Sex frequency</td><td align="center" valign="middle" >Daily</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >3 times/week</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Weekly</td><td align="center" valign="middle" >200</td><td align="center" valign="middle" >100</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Condom use</td><td align="center" valign="middle" >Often</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Occasionally</td><td align="center" valign="middle" >200</td><td align="center" valign="middle" >100</td></tr><tr><td align="center" valign="middle" >Rarely</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr></tbody></table></table-wrap><p>viruses revealed an average ratio of 1.7 and a concentration of 105 &#181;g/ml. The base pair for CCR5 wild and mutant types were 226 bp and 192 bp respectively (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Wild type of CCR5 genotype was identified among all HIV patients subject and in 95.5% (193/200) of sex worker group while mutant CCR5-delta 32 genotype was detected only in 3.5% (7/200) of sex workers. A Chi-Square value of 0.008 was found as a significant association of CCR5-delta 32 genotype detection between HIV and sex workers groups (<xref ref-type="table" rid="table3">Table 3</xref>).</p></sec><sec id="s4"><title>4. Discussion</title><p>Genetic studies related to HIV/AIDS in the population help to understand susceptibility to the disease and opportunities for control, treatment and vaccination [<xref ref-type="bibr" rid="scirp.117362-ref13">13</xref>]. Throughout the world, one of the most documented natural resistance genetic characters against HIV acquisition is the presence of CCR5-delta 332 mutation, however, many countries such as Sudan lack the necessary information [<xref ref-type="bibr" rid="scirp.117362-ref10">10</xref>]. This is almost due to reasons related to the available resources that limit the implementation of such projects, especially the cost of national surveys, thus up to date, no findings were recorded about the frequency of the CCR5-delta 32 gene among the Sudanese population. Some conclusions have also limited the existence of CCR5-delta 32 mutation in the regions of North Europe, West Asia and North Africa [<xref ref-type="bibr" rid="scirp.117362-ref14">14</xref>], such a study indicates the possibility of having a mutation in the Sudanese population.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Distribution of CCR5 genotypes (homozygous and heterozygous) among HIV and sex workers groups</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Study subject</th><th align="center" valign="middle"  colspan="2"  >CCR5-delta 32</th><th align="center" valign="middle"  rowspan="2"  >Total</th><th align="center" valign="middle"  rowspan="2"  >P. value</th></tr></thead><tr><td align="center" valign="middle" >CCR5/CCR5</td><td align="center" valign="middle" >CCR5-delta 32/CCR5-delta 32</td></tr><tr><td align="center" valign="middle" >HIV cases</td><td align="center" valign="middle" >200</td><td align="center" valign="middle" >0.0</td><td align="center" valign="middle" >200</td><td align="center" valign="middle"  rowspan="3"  >0.008</td></tr><tr><td align="center" valign="middle" >Sex workers</td><td align="center" valign="middle" >193</td><td align="center" valign="middle" >7.0</td><td align="center" valign="middle" >200</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >393</td><td align="center" valign="middle" >7.0</td><td align="center" valign="middle" >400</td></tr></tbody></table></table-wrap><p>Results of this study indicated what had been stated globally; HIV in Sudan mostly affects those ages that are less than 50 years [<xref ref-type="bibr" rid="scirp.117362-ref3">3</xref>]. The records of the study of HIV cases showed that males were more infected in Sudan; the reason for this is the effectiveness of the transmission of HIIV through sex among men, which had been confirmed in a previous study [<xref ref-type="bibr" rid="scirp.117362-ref15">15</xref>]. The current study observed an accumulation of HIV cases at a low educational level; this is an epidemiological indicator that eliminates sufficient knowledge of transmission methods of HIV infection and prevention measures [<xref ref-type="bibr" rid="scirp.117362-ref16">16</xref>]. On the other hand, the sex workers group of this study also lacks a high level of education which could be linked to low personal income and instability.</p><p>From all existent data regarding the presence and frequency of CCR5-delta 32, it is difficult to say whether it is only associated with a particular race or not. And it can be said that the rating of presence varies, as the countries of Northern Europe have high rates of presence and East Asian [<xref ref-type="bibr" rid="scirp.117362-ref17">17</xref>] and Africa have the lowest [<xref ref-type="bibr" rid="scirp.117362-ref18">18</xref>]. Information about rating of CCR5-delta 32 genetic mutation in Africa is very limited and insufficient to be generalized, on the other hand, the hypothesis that there is resistance to AIDS in some African populations has been studied as indicating a resistance relationship between the CCR5-delta 24 mutation that has an effectible impact on the CCR5 addressing [<xref ref-type="bibr" rid="scirp.117362-ref19">19</xref>].</p><p>Our result is the first finding of the homozygous CCR5-delta 32 gene among Sudanese with HIV and sex workers; it is a higher recorded rate than in most African countries, which could be referred to as the characteristic of the Sudanese human being, in which black and white elements are mixed [<xref ref-type="bibr" rid="scirp.117362-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.117362-ref21">21</xref>]. In line, our result is not in agreement with other studies conducted on the African populations from Nigeria [<xref ref-type="bibr" rid="scirp.117362-ref22">22</xref>] and Cameroon [<xref ref-type="bibr" rid="scirp.117362-ref23">23</xref>]. The result yielded from this study, indicated that the rating of CCR5-Delta 32 Homozygous mutation was 3.5% in Sudaneses HIV patients and Sex Workers, while in some studies in African population indicated the absence of this mutation, their results may differ when studying a larger sample size representing the whole community. Since the homozygous gene is inherited from two carrier parents, the obtained percentage of the CCR5-delta 32 allele indicates the presence of more carriers in the Sudanese population. The conclusion of this study is the presence of the gene responsible for HIV resistance in sex workers in a significant proportion compared to the HIV studied patients. Also, the studied Sudanese subjects showed a higher percentage of the gene than most African countries, and within the limits of what is had been estimated for African countries north of the Sahara.</p></sec><sec id="s5"><title>Study Limitation</title><p>This study was limited to two studied groups that do not represent the entire Sudanese population, which consists of several different races.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Fath-Elrahman, M.H., Alkarsany, M., Mohammed Nour, B.Y., Abakar, A.D., Mhammed, A.E., Elzaki, S.G., Osman, E., Elshafia, M. and Ahmed, E.A. (2022) Rating of CCR5-Delta 32 Homozygous Mutation in Sudanese HIV Patients and Sex Workers. World Journal of AIDS, 12, 55-64. https://doi.org/10.4236/wja.2022.122005</p></sec></body><back><ref-list><title>References</title><ref id="scirp.117362-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">WHO (2021) HIV/AIDS. https://www.who.int/news-room/fact-sheets/detail/hiv-aids</mixed-citation></ref><ref id="scirp.117362-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Karamouzian, M., Madani, N., Doroudi, F. and Haghdoost, A.A. (2017) Improving the Quality and Quantity of HIV Data in the Middle East and North Africa: Key Challenges and Ways Forward. International Journal of Health Policy and Management, 6, 65-69. https://doi.org/10.15171/ijhpm.2016.112</mixed-citation></ref><ref id="scirp.117362-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">WHO (2017) EMRO Regional Surveillance Data, HIV Test-Treatretain Cascade Analysis: Guide and Tools. 2nd Edition.</mixed-citation></ref><ref id="scirp.117362-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Toyoda, M., Ogata, Y., Mahiti, M., et al. (2015) Differential Ability of Primary HIV-1 Nef Isolates to Downregulate HIV-1 Entry Receptors. Journal of Virology, 89, 9639-9652. https://doi.org/10.1128/JVI.01548-15</mixed-citation></ref><ref id="scirp.117362-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Henrich, T.J., Hanhauser, E., Hu, Z., Stellbrink, H.J., Noah, C., Martin, J.N., Deeks, S.G., Kuritzkes, D.R. and Pereyra, F. (2015) Viremic Control and Viral Coreceptor Usage in Two HIV-1-Infected Persons Homozygous for CCR5 Δ32. AIDS, 29, 867-876. https://doi.org/10.1097/QAD.0000000000000629</mixed-citation></ref><ref id="scirp.117362-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Nascimento-Brito, S., Paulo Zukurov, J., Maricato, J.T., Volpini, A.C., Salim, A.C.M., Araújo, F.M.G., et al. (2015). HIV-1 Tropism Determines Different Mutation Profiles in Proviral DNA. PLoS ONE, 10, e0139037. https://doi.org/10.1371/journal.pone.0139037</mixed-citation></ref><ref id="scirp.117362-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Ronsard, L., Sood, V., Yousif, A.S., Ramesh, J., Shankar, V., Das, J., Sumi, N., Rai, T., Mohankumar, K., Sridharan, S., Dorschel, A., Ramachandran, V.G. and Banerjea, A.C. (2019) Genetic Polymorphisms in the Open Reading Frame of the CCR5 gene from HIV-1 Seronegative and Seropositive Individuals From National Capital Regions of India. Scientific Reports, 9, Article No. 7594. https://doi.org/10.1038/s41598-019-44136-z</mixed-citation></ref><ref id="scirp.117362-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">O’Hayre, M., Salanga, C.L., Handel, T.M. and Hamel, D.J. (2010) Emerging Concepts and Approaches for Chemokine-Receptor Drug Discovery. Expert Opinion on Drug Discovery, 5, 1109-1122. https://doi.org/10.1517/17460441.2010.525633</mixed-citation></ref><ref id="scirp.117362-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Marmor, M., Sheppard, H.W., Donnell, D., Bozeman, S. and Celum, C. (2001) Homozygous and Heterozygous CCR5-Δ32 Genotypes Are Associated with Resistance to HIV Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes, 27, 472-481. https://doi.org/10.1097/00126334-200108150-00009</mixed-citation></ref><ref id="scirp.117362-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Solloch, U.V., Lang, K., Lange, V., B&amp;#246;hme, I., Schmidt, A.H. and Sauter, J. (2017) Frequencies of Gene Variant CCR5-Δ32 in 87 Countries Based on Next-Generation Sequencing of 1.3 Million Individuals Sampled from 3 National DKMS Donor Centers. Human Immunology, 78, 710-717. https://doi.org/10.1016/j.humimm.2017.10.001</mixed-citation></ref><ref id="scirp.117362-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Wang, C., Wang, X., Wang, H., Pu, J., Li, Q., Li, J., Liu, Y., Lu, L. and Jiang, S. (2021) A “Two-Birds-One-Stone” Approach toward the Design of Bifunctional Human Immunodeficiency Virus Type 1 Entry Inhibitors Targeting the CCR5 Coreceptor and gp41 N-Terminal Heptad Repeat Region. Journal of Medicinal Chemistry, 64, 11460-11471. https://doi.org/10.1021/acs.jmedchem.1c00781</mixed-citation></ref><ref id="scirp.117362-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Ahlenstiel, G., Berg, T., Woitas, R.P., et al. (2003) Effects of the CCR5-Δ32 Mutation on Antiviral Treatment in Chronic Hepatitis C. Journal of Hepatology, 39, 245-252. https://doi.org/10.1016/S0168-8278(03)00193-4</mixed-citation></ref><ref id="scirp.117362-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Hamid, T.A.M., Hamza, B.O.E. and Gaufri, N.A.M. (2021). Frequency of CCR5-Δ32 Mutant Allele in Sudanese Patients with Sickle Cell Anemia. Asian Hematology Research Journal, 4, 29-34. https://www.journalahrj.com/index.php/AHRJ/article/view/30148</mixed-citation></ref><ref id="scirp.117362-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Marmor, M., Hertzmark, K., Thomas, S.M., Halkitis, P.N. and Vogler, M. (2006) Resistance to HIV Infection. Journal of Urban Health, 83, 5-17. https://doi.org/10.1007/s11524-005-9003-8</mixed-citation></ref><ref id="scirp.117362-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Novembre, J., Galvani, A.P. and Slatkin, M. (2005) The Geographic Spread of the CCR5Δ32 HIV-Resistance Allele. PLoS Biology, 3, e339. https://doi.org/10.1371/journal.pbio.0030339</mixed-citation></ref><ref id="scirp.117362-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Nasirian, M., Kianersi, S., Karamouzian, M., et al. (2020) HIV Modes of Transmission in Sudan in 2014. International Journal of Health Policy and Management, 9, 108-115. https://doi.org/10.15171/ijhpm.2019.91</mixed-citation></ref><ref id="scirp.117362-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Kayeyi, N., Sand&amp;#248;y, I.F. and Fylkesnes, K. (2009) Effects of Neighbourhood-Level Educational Attainment on HIV Prevalence among Young Women in Zambia. BMC Public Health 9, Article No. 310. https://doi.org/10.1186/1471-2458-9-310</mixed-citation></ref><ref id="scirp.117362-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Tajbakhsh, A., Fazeli, M., Rezaee, M., et al. (2019) Prevalence of CCR5delta32 in Northeastern Iran. BMC Medical Genetics, 20, Article No. 184. https://doi.org/10.1186/s12881-019-0913-9</mixed-citation></ref><ref id="scirp.117362-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Sabeti, P.C., Walsh, E., Schaffner, S.F., Varilly, P., Fry, B., Hutcheson, H.B., Cullen, M., Mikkelsen, S.T., Roy, J., Patterson, N., Cooper, R., Reich, D., Altshuler, D., O’Brien, S. and Lander, E.S. (2005) The Case for Selection at CCR5-Δ32. PLoS Biology, 3, e378. https://doi.org/10.1371/journal.pbio.0030378</mixed-citation></ref><ref id="scirp.117362-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Arendt, V., Amand, M., Iserentant, G., et al. (2019) Predominance of the Heterozygous CCR5 Delta-24 Deletion in African Individuals Resistant to HIV Infection Might Be Related to a Defect in CCR5 Addressing at the Cell Surface. Journal of the International AIDS Society, 22, e25384. https://doi.org/10.1002/jia2.25384</mixed-citation></ref><ref id="scirp.117362-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Sharkey, H.J. (2008) Arab Identity and Ideology in Sudan: The Politics of Language, Ethnicity, and Race. African Affairs, 107, 21-43. https://doi.org/10.1093/afraf/adm068</mixed-citation></ref><ref id="scirp.117362-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Ekere, E.F., Useh, M.F., Okoroiwu, H.U., et al. (2020) Cysteine-Cysteine Chemokine Receptor 5 (CCR5) Profile of HIV-Infected Subjects Attending University of Calabar Teaching Hospital, Calabar, Southern Nigeria. BMC Infectious Diseases, 20, Article No. 5. https://doi.org/10.1186/s12879-019-4737-1</mixed-citation></ref><ref id="scirp.117362-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Torimiro, J.N., Wolfe, N.D., Thomas, A., Martin, M.P., Mpoudi-Ngole, E., Tamoufe, U., Birx, D.L., Carrington, M., Burke, D.S. and Carr, J.K. (2007) Frequency of CCR5 Variants among Rural Populations with Low HIV-1 Prevalence in Cameroon. AIDS, 21, 527-528. https://doi.org/10.1097/QAD.0b013e328045c4bd</mixed-citation></ref></ref-list></back></article>